AsclepiX Therapeutics
Baltimore, US
Biotech
Founders & leadership
AS
Aleksander S. Popel, PhDExecutive Officer, Director
JJ
Jordan J. GreenExecutive Officer, Director
WP
Wendy PerrowExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$10MraisedApr 2024 · 9 investors · Biotechnology
Rule 506(b)$10MraisedJun 2020 · 34 investors · Biotechnology
Rule 506(b)$7.7MraisedJun 2019 · 26 investors · Biotechnology
Rule 506(b)$175KraisedFeb 2017 · 5 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.